Biotech News
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
ir.genfit.com2026-05-06 15:04 EST
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), January 13, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity